Reviewed
Verified by SAC team
+20
XP on completion
Classic 3-in-1 Blend
Solaray

Solaray QBC Plex (Quercetin, Bromelain & Vitamin C) Review

Solaray's QBC Plex is the old-school stack: quercetin plus bromelain plus vitamin C in one veg cap, roughly 500 mg quercetin per serving. It's a legacy formula with a loyal following and a vitamin C co-factor that fits the antioxidant angle. It ranks mid-pack because the quercetin dose is modest, it's plain (non-phytosome) quercetin, and the 'vitamin C boosts quercetin absorption' idea is mechanistic, not established in humans.

Check on Amazon

Affiliate link — Super Achiever Club earns a small commission at no extra cost to you.

Read the complete Quercetin guide →
▸ THE SCORE

How we built the SAC Product Score™6/10

Bioavailability / Form30%5.8/10

Plain quercetin, so baseline absorption is low. Vitamin C is included partly on an absorption-cofactor theory that is mechanistic/animal-based rather than established in humans.

Dose vs Clinical Range20%5.8/10

~500 mg quercetin per serving is toward the lower end of the studied range, and it's split across three actives, so the quercetin portion is modest.

Third-Party Testing / Purity20%6/10

Vegan, lab verified with a 60-day guarantee from an established brand. Adequate, not standout, transparency.

Tolerability & Safety15%7/10

Well tolerated; the three-active blend keeps individual doses modest, and vitamin C is benign at these levels. Usual bromelain cautions apply.

Value15%5.6/10

~$16 for 60 caps is fair for a 3-in-1, but the low quercetin content per dollar keeps value middling.

▸ SPECS

The product at a glance

Form
Quercetin + bromelain + vitamin C blend, veg capsule
Dose
~500 mg quercetin + bromelain + vitamin C per serving
Count
60 veg capsules
Standardization
Vegan, lab verified
Testing
Lab verified; 60-day guarantee
Cost per dose
~$0.27 per serving (~$16/60)
▸ TRUTH CHECK

Marketing claims vs. reality

Not verified

Vitamin C enhances quercetin absorption and stability

The vitamin-C-aids-quercetin idea rests on mechanistic and animal data; there's no solid human pharmacokinetic trial confirming meaningfully higher quercetin absorption from added vitamin C.

Partial

The three-in-one blend supports immune and allergy health

Each component has plausible immune/anti-inflammatory rationale (Mlcek 2016, PMID 27187333 for quercetin's anti-allergic mechanisms), but combined human outcome trials for this specific blend are lacking.

▸ THE DEEP DIVE

What our test actually found

01Convenience of one cap, at a dose cost

Getting quercetin, bromelain and vitamin C in a single legacy formula is convenient, but bundling means the quercetin dose is modest compared with dedicated high-dose combos.

02The vitamin C synergy is marketing-forward

The appeal of QBC leans on the vitamin-C-helps-quercetin narrative, which isn't backed by human PK data. It's a fine antioxidant cofactor, just not a proven absorption enhancer.

▸ THE TRADE-OFFS

Pros & cons, no sugar-coating

Pros
  • Three complementary actives (quercetin + bromelain + vitamin C) in one cap
  • Long-standing formula with a loyal track record
  • Vitamin C adds a legitimate antioxidant cofactor
  • Backed by a 60-day guarantee
Cons
  • Modest per-serving quercetin dose split across three actives
  • Plain quercetin means low absorption
  • Vitamin-C-boosts-quercetin claim isn't established in humans
▸ THE BOTTOM LINE

A convenient legacy blend, not a dose leader

QBC Plex is a reasonable one-cap way to cover the classic quercetin-bromelain-C trio with a trusted name behind it. It ranks mid-pack because the quercetin dose is modest, absorption is plain-powder tier, and the vitamin C synergy is more marketing than proven science.

Check Solaray on Amazon
▸ ALTERNATIVES

If this doesn’t fit — try these

▸ RESEARCH

Sources & further reading

  1. Mlcek J, et al. Molecules. 2016;21(5):623.Mlcek J, Jurikova T, Skrovankova S, Sochor J · 2016 · Molecules · PMID 27187333

    Quercetin and Its Anti-Allergic Immune Response

    Summarizes quercetin's mast-cell and anti-allergic mechanisms, which remain largely preclinical rather than confirmed in large human allergy trials.

  2. Heinz SA, et al. Pharmacol Res. 2010;62(3):237-242.Heinz SA, Henson DA, Austin MD, et al. · 2010 · Pharmacological Research · PMID 20478383

    Quercetin supplementation and upper respiratory tract infection

    Found no whole-population URTI benefit from quercetin, reinforcing that modest-dose blends should be viewed as supportive, not curative.